Study of the Genetics of Pericarditis Increases Understanding of Newly Approved Drug Treatment

Sequence variants that protect against pericarditis have been discovered at a genomic locus encoding interleukin-1 immune cytokines. A newly approved drug treatment for pericarditis inhibits these cytokines and a new study from deCODE genetics and collaborators can contribute to the further development of this treatment. The new study called “Variants at The Interleukin-1 Gene Locus and Pericarditis” was published on December 27, 2023 in JAMA Cardiology by scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Denmark, USA, and Iceland.

Login Or Register To Read Full Story